Mylinh Duong, PhD^*, Jihyun Park, PhD^*, Joseph Senesac, MSc, MBA^*, Raphael Ognar, MSc, MBA, Simon Wain-Hobson, DPhil^* and Henri Bayle, PhD

NKILT Therapeutics, Houston, TX

Casey Bermack, MD, PhD¹, Ke Pan, PhD^2*, Yulun Chiu, PhD^2*, Luis Malpica, MD^1*, Swaminathan P Iyer, MD^1*, Christopher R. Flowers, MD, MS¹ and Cassian Yee, MD^2*

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Sheryl Y. T. Lim, DPhil^1*, Frances M. Cole^1*, George S. Laszlo, PhD^2*, Margaret C. Lunn-Halbert^1*, Jenny Huo^1*, Junyang Li^1*, Allie R. Kehret^1* and Roland B. Walter, MD, PhD, MS^3,4,5

¹Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
²1100 Fairview Avenue North, Fred Hutchinson Cancer Center, Seattle, WA
³Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA
⁴Fred Hutchinson Cancer Center, Seattle, WA
⁵Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA

Diana Chin, MS^*, Andriana Lebid, Ph.D.^*, Kaitlin Idank^*, Mark Mendonca^*, Arina Perez^*, Nicholas Alexander^*, Steven DeLuca^*, Charles Dominick^*, Buddha Gurung, Ph.D.^*, Barry Morse, Ph.D.^*, Liam Campion, MS^*, Daniel Perry, Ph.D.^*, Michael Naso, Ph.D.^*, Hy Levitsky, MD and Hillary Quinn, MS^*

Century Therapeutics, Philadelphia, PA

Francesco Mazziotta, MD, PhD¹, Lauren E Martin^1*, Daniel Eagan, MD^1*, Filippo Milano, MD², Valentin Voillet^1*, Tzu-Hao Tang^1*, Miranda Lahman, PhD^1*, Sinéad Kinsella, MSc, PhD^1*, Kelly Paulson, MD, PhD^3*, Philip D Greenberg, MD^1* and Aude G Chapuis, MD¹

¹Fred Hutchinson Cancer Center, Seattle, WA
²Fred Hutchinson Cancer Research Center, Seattle, WA
³Swedish Cancer Institute Medical Oncology, Seattle

Jaya Lakshmi Thangaraj, M.Tech, PhD.^1*, Edith Lopez^2* and Dan S Kaufman, MD, PhD³

¹Department of Medicine, Division of Regenerative Medicine, University of California San Diego, San Diego, CA
²Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, San Diego, CA
³University of California San Diego, La Jolla, CA

David N. Sedloev, MD^1*, Qian Chen^2*, Julia M. Unglaub, MD^3*, Anita Schmitt, MD^4*, Carsten Müller-Tidow, MD^3,5*, Michael Schmitt, MD^4* and Tim Sauer, MD³

¹Heidelberg Myeloma Center, Department of Medicine V, Heidelberg University Hospital, Heidelberg, AL, Germany
²Heidelberg University Hospital, Heidelberg, Germany
³Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
⁴Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany
⁵European Molecular Biology Lab (EMBL), Molecular Medicine Partnership Unit, Heidelberg, Germany

Dongyao Wang, PhD^1,2,3*, Chuang Yuan^4*, Yue Wu^5*, Xingchi Chen^5*, Guangyu Sun^6*, Aijie Huang, MD^7*, Xiaoyu Zhu^8,9 and Haiming Wei, MD^10*

¹Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei City, Anhui Province, China
²Center for Cancer Immunology and Cutaneous Biology Research Center, Department of Dermatology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA
³Institute of Immunology, School of Basic Medicine and Medical Center, University of Science and Technology of China, Hefei, China
⁴Peking University, Beijing, China
⁵Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230027, China, Hefei, China
⁶Blood and Cell Therapy Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, Heifei, China
⁷The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Shanghai, China
⁸Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Hefei, China
⁹Blood and Cell Therapy Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
¹⁰Institute of Immunology, School of Basic Medicine and Medical Center, University of Science and Technology of China, Hefei, Anhui, 230001, China., Hefei, CHN

Eva Castellano^1*, Almudena García-Ortiz, PhD^1*, Laura Ugalde, PhD^2*, Elena Maroto Martin, PhD^1*, Jessica Encinas Mayoral, PhD^1*, Raquel Oliva^1*, Laura Garcia-Garcia^2*, Irene Peña^2*, Noemi Álvarez^1*, Gonzalo Carreño, PhD^3*, Rosa Ayala, MD, PhD^4*, Laura Cordoba^1*, Alejandra Leivas, PhD^1*, Guillermo Suñe^5*, Beatriz Martin Antonio, PhD^6*, Rafael Alonso Fernandez, MD^7*, Maria Teresa Cedena Romero, MD, PhD^1*, Joaquín Martínez-Lopez^4*, Paula Rio, PhD² and Antonio Valeri, PhD^1*

¹Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain
²Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Biomedical research center in rare disease netwotk (CIBERER) and Fund Jiménez Díaz Research Institute, Madrid, Spain
³Hospital Universitario 12 de Octubre, Madrid, Spain
⁴Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain, Madrid, Spain
⁵Clinic Barcelona Hospital/IDIBAPS, Department of Hematology, ICMHO, Barcelona, Spain, Madrid, Spain
⁶Department of Experimental Hematology, Fundación Jiménez Díaz research institute, Madrid, Spain., Madrid, Spain
⁷Department of Hematology, Hospital Universitario 12 de Octubre-Universidad Complutense, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain

Valentina Grillo Alvarado, BS^1,2*, Ryma Toumi, PhD^2*, Aidan Schutte^3*, Aitong Ruan^2* and Shannon Oda, PhD²

¹Molecular and Cellular Biology Graduate Program, University of Washington, Seattle
²Seattle Children's Research Institute, Seattle, WA
³University of Washington, Seattle

Ulrike Regina Schmits^1*, Edite Antunes Ferreira^2*, Borhane Guezguez, PhD^2,3*, David Gomez-Zepeda^4,5*, Stefan Tenzer^4,5,6*, Kevin Jan Legscha^2*, Matthias Theobald, MD^3,6,7 and Hakim Echchannaoui, PhD^2,3*

¹Department of Hematology and Medical Oncology, University Medical Center (UMC) Mainz, Mainz, AL, Germany
²Department of Hematology and Medical Oncology, University Medical Center (UMC) Mainz, Mainz, Germany
³German Cancer Consortium (DKTK), Partner site Frankfurt/Mainz, Mainz, Germany
⁴Helmholtz Institute for Translational Oncology Mainz (HI-TRON Mainz), Mainz, Germany
⁵DKFZ German Cancer Research Center, Heidelberg, Germany
⁶Institute of Immunology, Research Center for Immunotherapy (FZI), Mainz, Germany
⁷Department of Hematology and Oncology, Medical Center of the Johannes Gutenberg University, Mainz, Germany